IBDEI12Y ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39216,0)
 ;;=D56.8^^148^1947^186
 ;;^UTILITY(U,$J,358.3,39216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39216,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,39216,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,39216,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,39217,0)
 ;;=C82.89^^148^1947^76
 ;;^UTILITY(U,$J,358.3,39217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39217,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,39217,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,39217,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,39218,0)
 ;;=D51.8^^148^1947^193
 ;;^UTILITY(U,$J,358.3,39218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39218,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,39218,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,39218,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,39219,0)
 ;;=I80.9^^148^1947^178
 ;;^UTILITY(U,$J,358.3,39219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39219,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,39219,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,39219,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,39220,0)
 ;;=D45.^^148^1947^179
 ;;^UTILITY(U,$J,358.3,39220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39220,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,39220,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,39220,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,39221,0)
 ;;=C77.3^^148^1947^109
 ;;^UTILITY(U,$J,358.3,39221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39221,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,39221,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,39221,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,39222,0)
 ;;=C77.2^^148^1947^125
 ;;^UTILITY(U,$J,358.3,39222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39222,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,39222,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,39222,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,39223,0)
 ;;=C77.1^^148^1947^126
 ;;^UTILITY(U,$J,358.3,39223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39223,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,39223,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,39223,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,39224,0)
 ;;=C77.0^^148^1947^142
 ;;^UTILITY(U,$J,358.3,39224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39224,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,39224,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,39224,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,39225,0)
 ;;=C77.8^^148^1947^143
 ;;^UTILITY(U,$J,358.3,39225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39225,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,39225,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,39225,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,39226,0)
 ;;=C79.51^^148^1947^113
 ;;^UTILITY(U,$J,358.3,39226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39226,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,39226,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,39226,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,39227,0)
 ;;=C79.52^^148^1947^112
 ;;^UTILITY(U,$J,358.3,39227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39227,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,39227,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,39227,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,39228,0)
 ;;=C79.31^^148^1947^114
 ;;^UTILITY(U,$J,358.3,39228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39228,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,39228,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,39228,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,39229,0)
 ;;=C79.72^^148^1947^129
 ;;^UTILITY(U,$J,358.3,39229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39229,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,39229,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,39229,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,39230,0)
 ;;=C78.02^^148^1947^133
 ;;^UTILITY(U,$J,358.3,39230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39230,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,39230,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,39230,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,39231,0)
 ;;=C78.7^^148^1947^138
 ;;^UTILITY(U,$J,358.3,39231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39231,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,39231,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,39231,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,39232,0)
 ;;=C79.71^^148^1947^151
 ;;^UTILITY(U,$J,358.3,39232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39232,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,39232,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,39232,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,39233,0)
 ;;=C78.01^^148^1947^155
 ;;^UTILITY(U,$J,358.3,39233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39233,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,39233,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,39233,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,39234,0)
 ;;=C79.70^^148^1947^106
 ;;^UTILITY(U,$J,358.3,39234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39234,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,39234,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,39234,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,39235,0)
 ;;=C78.00^^148^1947^139
 ;;^UTILITY(U,$J,358.3,39235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39235,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,39235,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,39235,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,39236,0)
 ;;=D57.1^^148^1947^182
 ;;^UTILITY(U,$J,358.3,39236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39236,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,39236,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,39236,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,39237,0)
 ;;=D75.1^^148^1947^180
 ;;^UTILITY(U,$J,358.3,39237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39237,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,39237,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,39237,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,39238,0)
 ;;=C90.30^^148^1947^183
 ;;^UTILITY(U,$J,358.3,39238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39238,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,39238,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,39238,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,39239,0)
 ;;=D56.3^^148^1947^184
 ;;^UTILITY(U,$J,358.3,39239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39239,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,39239,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,39239,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,39240,0)
 ;;=D56.9^^148^1947^185
 ;;^UTILITY(U,$J,358.3,39240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39240,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,39240,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,39240,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,39241,0)
 ;;=M31.1^^148^1947^187
 ;;^UTILITY(U,$J,358.3,39241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39241,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,39241,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,39241,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,39242,0)
 ;;=D51.2^^148^1947^188
 ;;^UTILITY(U,$J,358.3,39242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39242,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,39242,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,39242,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,39243,0)
 ;;=D05.92^^148^1947^35
 ;;^UTILITY(U,$J,358.3,39243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39243,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
